CD274 and neoplasm: Moreover, through PD-L1/PD-L2 expression, DC can engage the PD-1 inhibitory pathway, thus inhibiting lymphocyte proliferation and effector functions [72,73], inducing tumor-specific T-cell apoptosis [74] and promoting the differentiation of CD4+ T-cells into Treg [75].